Cancer Metabolism: Current Understanding and Therapies

被引:173
作者
Counihan, Jessica L. [1 ,2 ,3 ,4 ]
Grossman, Elizabeth A. [1 ,2 ,3 ,4 ]
Nomura, Daniel K. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Toxicol, Berkeley, CA 94720 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
FATTY-ACID SYNTHASE; COA-CARBOXYLASE-ALPHA; PROTEIN; 90; INHIBITOR; ATP CITRATE LYASE; CELL LUNG-CANCER; INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; GERANYLGERANYLTRANSFERASE-I INHIBITORS; ORNITHINE-DECARBOXYLASE ACTIVITY; ACUTE LYMPHOBLASTIC-LEUKEMIA; INTRACELLULAR FOLATE POOLS;
D O I
10.1021/acs.chemrev.7b00775
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Dysregulation of cancer cell metabolism contributes to abnormal cell growth, the biological end point of cancer. We review here numerous affected oncogenes and metabolic pathways common in cancer and how they contribute to cancer pathogenesis and malignancy. This review also discusses various pharmacological manipulations that take advantage of these metabolic abnormalities and the current targeted therapies that have arisen from this research.
引用
收藏
页码:6893 / 6923
页数:31
相关论文
共 412 条
[1]   Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling [J].
Adam, Julie ;
Hatipoglu, Emine ;
O'Flaherty, Linda ;
Ternette, Nicola ;
Sahgal, Natasha ;
Lockstone, Helen ;
Baban, Dilair ;
Nye, Emma ;
Stamp, Gordon W. ;
Wolhuter, Kathryn ;
Stevens, Marcus ;
Fischer, Roman ;
Carmeliet, Peter ;
Maxwell, Patrick H. ;
Pugh, Chris W. ;
Frizzell, Norma ;
Soga, Tomoyoshi ;
Kessler, Benedikt M. ;
El-Bahrawy, Mona ;
Ratcliffe, Peter J. ;
Pollard, Patrick J. .
CANCER CELL, 2011, 20 (04) :524-537
[2]   Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction [J].
Al-Wahab, Zaid ;
Mert, Ismail ;
Tebbe, Calvin ;
Chhina, Jasdeep ;
Hijaz, Miriana ;
Morris, Robert T. ;
Ali-Fehmi, Rouba ;
Giri, Shailendra ;
Munkarah, Adnan R. ;
Rattan, Ramandeep .
ONCOTARGET, 2015, 6 (13) :10908-10923
[3]  
ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478
[4]   From Krebs to clinic: glutamine metabolism to cancer therapy [J].
Altman, Brian J. ;
Stine, Zachary E. ;
Dang, Chi V. .
NATURE REVIEWS CANCER, 2016, 16 (10) :619-634
[5]   Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas [J].
Amar, Laurence ;
Baudin, Eric ;
Burnichon, Nelly ;
Peyrard, Severine ;
Silvera, Stephane ;
Bertherat, Jerome ;
Bertagna, Xavier ;
Schlumberger, Martin ;
Jeunemaitre, Xavier ;
Gimenez-Roqueplo, Anne-Paule ;
Plouin, Pierre-Francois .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (10) :3822-3828
[6]   Serine and glycine metabolism in cancer [J].
Amelio, Ivano ;
Cutruzzola, Francesca ;
Antonov, Alexey ;
Agostini, Massimiliano ;
Melino, Gerry .
TRENDS IN BIOCHEMICAL SCIENCES, 2014, 39 (04) :191-198
[7]   Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis [J].
Anastasiou, Dimitrios ;
Yu, Yimin ;
Israelsen, William J. ;
Jiang, Jian-Kang ;
Boxer, Matthew B. ;
Hong, Bum Soo ;
Tempel, Wolfram ;
Dimov, Svetoslav ;
Shen, Min ;
Jha, Abhishek ;
Yang, Hua ;
Mattaini, Katherine R. ;
Metallo, Christian M. ;
Fiske, Brian P. ;
Courtney, Kevin D. ;
Malstrom, Scott ;
Khan, Tahsin M. ;
Kung, Charles ;
Skoumbourdis, Amanda P. ;
Veith, Henrike ;
Southall, Noel ;
Walsh, Martin J. ;
Brimacombe, Kyle R. ;
Leister, William ;
Lunt, Sophia Y. ;
Johnson, Zachary R. ;
Yen, Katharine E. ;
Kunii, Kaiko ;
Davidson, Shawn M. ;
Christofk, Heather R. ;
Austin, Christopher P. ;
Inglese, James ;
Harris, Marian H. ;
Asara, John M. ;
Stephanopoulos, Gregory ;
Salituro, Francesco G. ;
Jin, Shengfang ;
Dang, Lenny ;
Auld, Douglas S. ;
Park, Hee-Won ;
Cantley, Lewis C. ;
Thomas, Craig J. ;
Heiden, Matthew G. Vander .
NATURE CHEMICAL BIOLOGY, 2012, 8 (10) :839-847
[8]  
Andrew Brenner J.I., First-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640 as monotherapy or in combination - final results of dose escalation
[9]  
[Anonymous], 2014, NAT COMMUN
[10]   A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets [J].
Arsham, AM ;
Howell, JJ ;
Simon, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29655-29660